Clinical trial
Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV
NCT00017992 · Triangle Pharmaceuticals, Industry · Unknown status
Key facts
| NCT number | NCT00017992 |
|---|---|
| Title | Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV |
| Official title | An Open-Label Study of a Once Daily Dose of Emtricitabine in Combination With Other Antiretroviral Agents in HIV-Infected Pediatric Patients |
| Lead sponsor | Triangle Pharmaceuticals, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Lopinavir/Ritonavir, Emtricitabine, Stavudine |
| Enrollment | 100 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | Argentina, Mexico, Panama, Puerto Rico, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: